Charles Zhao

Improved Survival of Lymphoma Patients with COVID-19 in the Modern Treatment and Vaccination Era

Jaeil Ahn, A. Goy, T. Feldman, 2022, Cancers.

Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors

W. Guo, R. Kurzrock, F. Janku, 2017, Investigational New Drugs.

Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer

M. Hidalgo, E. Van Cutsem, E. Raymond, 2018, International journal of cancer.

An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer

G. Sonpavde, M. Ernstoff, M. Carducci, 2014, Cancer.

Anti-spike antibody response to the COVID vaccine in lymphoma patients

Jaeil Ahn, A. Goy, T. Feldman, 2022, PloS one.